Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients

Yitao Gong,1– 4,* Zhiyao Fan,1– 4,* Guopei Luo,1– 4,* Qiuyi Huang,1– 4 Yunzhen Qian,1– 4 He Cheng,1– 4 Kaizhou Jin,1– 4 Quanxing Ni,1– 4 Xianjun Yu,1– 4 Chen Liu1– 4 1Department of Pancreatic Surgery,...

Full description

Bibliographic Details
Main Authors: Gong Y, Fan Z, Luo G, Huang Q, Qian Y, Cheng H, Jin K, Ni Q, Yu X, Liu C
Format: Article
Language:English
Published: Dove Medical Press 2020-08-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/absolute-counts-of-peripheral-lymphocyte-subsets-correlate-with-the-pr-peer-reviewed-article-CMAR
_version_ 1818849414342508544
author Gong Y
Fan Z
Luo G
Huang Q
Qian Y
Cheng H
Jin K
Ni Q
Yu X
Liu C
author_facet Gong Y
Fan Z
Luo G
Huang Q
Qian Y
Cheng H
Jin K
Ni Q
Yu X
Liu C
author_sort Gong Y
collection DOAJ
description Yitao Gong,1– 4,* Zhiyao Fan,1– 4,* Guopei Luo,1– 4,* Qiuyi Huang,1– 4 Yunzhen Qian,1– 4 He Cheng,1– 4 Kaizhou Jin,1– 4 Quanxing Ni,1– 4 Xianjun Yu,1– 4 Chen Liu1– 4 1Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China; 3Shanghai Pancreatic Cancer Institute, Shanghai 200032, People’s Republic of China; 4Pancreatic Cancer Institute, Fudan University, Shanghai 200032, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xianjun Yu; Chen LiuDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, No. 270 DongAn Road, Shanghai 200032, People’s Republic of ChinaTel + 86 21-64175590 ext 1307Fax + 86 21-64031446Email yuxianjun@fudanpci.org; liuchen@fudanpci.orgPurpose: Pancreatic neuroendocrine tumours (panNETs) are rare tumours of pancreas. Lymphocyte subsets in the peripheral blood are reported to reflect tumour prognosis and progression. The objective of the study is to investigate the hypotheses that the levels of peripheral lymphocytes may reflect tumour progression and may predict the prognosis of pancreatic neuroendocrine tumours (panNETs).Patients and Methods: A retrospective cohort study consisting of 73 patients diagnosed with panNETs was conducted. Kaplan–Meier methods and Log rank tests were used to compare the survival rates, and a Cox regression model was used to perform multivariate analyses.Results: panNET patients with distant metastasis were associated with lower peripheral total T cell (p = 0.039) and CD4+ T cell (p = 0.006) counts. Lower peripheral B cells (p = 0.007) and higher peripheral NK cell (p = 0.001) counts indicated worse progression-free survival (PFS) in Log rank tests. In multivariate analyses, low B cell count (hazard ratio (HR): 6.769, 95% confidence interval (CI): 2.158 to 21.228, p = 0.001) and high NK cell count (HR: 3.715, 95% CI: 1.164 to 11.855, p = 0.027) were independent risk factors for progression. NK cells and B cells were also significantly associated with PFS following radical surgical resection.Conclusion: Peripheral total T cell and CD4+ T cell counts may reflect the distant metastasis status in panNET patients. The absolute count of peripheral B cells and NK cells may independently predict the progression of panNET patients, making them promising prognostic indicators and potential targets for treatment of panNETs.Keywords: pancreatic neuroendocrine tumours, panNETs, lymphocyte subsets, progression-free survival, B cells
first_indexed 2024-12-19T06:32:51Z
format Article
id doaj.art-98b5c387e415468fb687f69382e847e7
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-12-19T06:32:51Z
publishDate 2020-08-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-98b5c387e415468fb687f69382e847e72022-12-21T20:32:20ZengDove Medical PressCancer Management and Research1179-13222020-08-01Volume 126727673755888Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour PatientsGong YFan ZLuo GHuang QQian YCheng HJin KNi QYu XLiu CYitao Gong,1– 4,* Zhiyao Fan,1– 4,* Guopei Luo,1– 4,* Qiuyi Huang,1– 4 Yunzhen Qian,1– 4 He Cheng,1– 4 Kaizhou Jin,1– 4 Quanxing Ni,1– 4 Xianjun Yu,1– 4 Chen Liu1– 4 1Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China; 3Shanghai Pancreatic Cancer Institute, Shanghai 200032, People’s Republic of China; 4Pancreatic Cancer Institute, Fudan University, Shanghai 200032, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xianjun Yu; Chen LiuDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, No. 270 DongAn Road, Shanghai 200032, People’s Republic of ChinaTel + 86 21-64175590 ext 1307Fax + 86 21-64031446Email yuxianjun@fudanpci.org; liuchen@fudanpci.orgPurpose: Pancreatic neuroendocrine tumours (panNETs) are rare tumours of pancreas. Lymphocyte subsets in the peripheral blood are reported to reflect tumour prognosis and progression. The objective of the study is to investigate the hypotheses that the levels of peripheral lymphocytes may reflect tumour progression and may predict the prognosis of pancreatic neuroendocrine tumours (panNETs).Patients and Methods: A retrospective cohort study consisting of 73 patients diagnosed with panNETs was conducted. Kaplan–Meier methods and Log rank tests were used to compare the survival rates, and a Cox regression model was used to perform multivariate analyses.Results: panNET patients with distant metastasis were associated with lower peripheral total T cell (p = 0.039) and CD4+ T cell (p = 0.006) counts. Lower peripheral B cells (p = 0.007) and higher peripheral NK cell (p = 0.001) counts indicated worse progression-free survival (PFS) in Log rank tests. In multivariate analyses, low B cell count (hazard ratio (HR): 6.769, 95% confidence interval (CI): 2.158 to 21.228, p = 0.001) and high NK cell count (HR: 3.715, 95% CI: 1.164 to 11.855, p = 0.027) were independent risk factors for progression. NK cells and B cells were also significantly associated with PFS following radical surgical resection.Conclusion: Peripheral total T cell and CD4+ T cell counts may reflect the distant metastasis status in panNET patients. The absolute count of peripheral B cells and NK cells may independently predict the progression of panNET patients, making them promising prognostic indicators and potential targets for treatment of panNETs.Keywords: pancreatic neuroendocrine tumours, panNETs, lymphocyte subsets, progression-free survival, B cellshttps://www.dovepress.com/absolute-counts-of-peripheral-lymphocyte-subsets-correlate-with-the-pr-peer-reviewed-article-CMARpancreatic neuroendocrine tumours (pannets)lymphocyte subsetsprogression-free survivalb cells
spellingShingle Gong Y
Fan Z
Luo G
Huang Q
Qian Y
Cheng H
Jin K
Ni Q
Yu X
Liu C
Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients
Cancer Management and Research
pancreatic neuroendocrine tumours (pannets)
lymphocyte subsets
progression-free survival
b cells
title Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients
title_full Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients
title_fullStr Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients
title_full_unstemmed Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients
title_short Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients
title_sort absolute counts of peripheral lymphocyte subsets correlate with the progression free survival and metastatic status of pancreatic neuroendocrine tumour patients
topic pancreatic neuroendocrine tumours (pannets)
lymphocyte subsets
progression-free survival
b cells
url https://www.dovepress.com/absolute-counts-of-peripheral-lymphocyte-subsets-correlate-with-the-pr-peer-reviewed-article-CMAR
work_keys_str_mv AT gongy absolutecountsofperipherallymphocytesubsetscorrelatewiththeprogressionfreesurvivalandmetastaticstatusofpancreaticneuroendocrinetumourpatients
AT fanz absolutecountsofperipherallymphocytesubsetscorrelatewiththeprogressionfreesurvivalandmetastaticstatusofpancreaticneuroendocrinetumourpatients
AT luog absolutecountsofperipherallymphocytesubsetscorrelatewiththeprogressionfreesurvivalandmetastaticstatusofpancreaticneuroendocrinetumourpatients
AT huangq absolutecountsofperipherallymphocytesubsetscorrelatewiththeprogressionfreesurvivalandmetastaticstatusofpancreaticneuroendocrinetumourpatients
AT qiany absolutecountsofperipherallymphocytesubsetscorrelatewiththeprogressionfreesurvivalandmetastaticstatusofpancreaticneuroendocrinetumourpatients
AT chengh absolutecountsofperipherallymphocytesubsetscorrelatewiththeprogressionfreesurvivalandmetastaticstatusofpancreaticneuroendocrinetumourpatients
AT jink absolutecountsofperipherallymphocytesubsetscorrelatewiththeprogressionfreesurvivalandmetastaticstatusofpancreaticneuroendocrinetumourpatients
AT niq absolutecountsofperipherallymphocytesubsetscorrelatewiththeprogressionfreesurvivalandmetastaticstatusofpancreaticneuroendocrinetumourpatients
AT yux absolutecountsofperipherallymphocytesubsetscorrelatewiththeprogressionfreesurvivalandmetastaticstatusofpancreaticneuroendocrinetumourpatients
AT liuc absolutecountsofperipherallymphocytesubsetscorrelatewiththeprogressionfreesurvivalandmetastaticstatusofpancreaticneuroendocrinetumourpatients